{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-029285","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2025-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.297345+00:00","generated_at":"2026-05-17T06:21:23.288481+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ekso Bionics enters $2M secured loan with B. Riley at 10% interest","bullets":["Agreement with B. Riley Commercial Capital for up to $2.0M secured term loan, maturing Sept 14, 2026 or upon qualified equity raise of $2.4M.","Interest at 10% per annum; exit fee of $200K (10% of principal) due at maturity.","Loan may convert into equity in connection with a qualified financing at the lead investor's price.","Existing $2.0M loan from Banc of California (Pacific Western Bank) terminated and fully paid off.","Proceeds for working capital and general corporate purposes; secured by substantially all personal property of company and subsidiary."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-029285","json":"https://secwatch.observer/filing/0001437749-25-029285.json","markdown":"https://secwatch.observer/filing/0001437749-25-029285.md","text":"https://secwatch.observer/filing/0001437749-25-029285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/0001437749-25-029285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/ekso20250917_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:21:23.288481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4adfe16e4b0736a20744e5d52feb9e3482149761","claim":"EKSO BIONICS HOLDINGS, INC. incurred term loan of $2.0 million with B. Riley Commercial Capital, LLC at 10.0% per annum maturing the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a “Qualified Financin.","evidence_excerpt":"On September 12, 2025, Ekso Bionics Holdings, Inc. (the “Company”) entered into a Secured Promissory Note and Security Agreement (the “Agreement”), by and among the Company, Ekso Bionics, Inc., a Delaware corporation and subsidiary of the Company (the “Subsidiary”), as guarantor, and B. Riley Commercial Capital, LLC, as lender (the “Lender”). The Agreement provides for a secured term loan in an aggregate principal amount of up to $2.0 million.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/0001437749-25-029285-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$2.0 million"},{"label":"Counterparty","value":"B. Riley Commercial Capital, LLC"},{"label":"Rate","value":"10.0% per annum"},{"label":"Maturity","value":"the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a “Qualified Financin"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}